PHOCRIZO (Crizotinib) 250mg Capsules | Pharma 2 Vientiane Laos Generic Xalkori for ALK+ NSCLC | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: PHOCRIZO 250 (Crizotinib Capsules) — Pharma 2 Vientiane

PHOCRIZO 250 is the crizotinib 250 mg capsule of Pharmaceutical Factory No.2 (Pharma 2 Vientiane), one of Laos' longest-established manufacturers, whose products carry the PHOKAM house mark. Each pack pairs a white high-density bottle with an outer carton and holds 60 capsules at 250 mg. The PHO- prefix runs through this factory's oncology family — PHODABRA, PHOCABO, PHOSOTOR and PHOCRIZO — a naming continuity that helps pharmacies and patients authenticate the line at a glance.

What Is PHOCRIZO Used to Treat?

PHOCRIZO delivers crizotinib for advanced non-small cell lung cancers whose tumors test positive for ALK or ROS1 rearrangements. Reference practice also recognizes crizotinib for ALK-positive systemic anaplastic large cell lymphoma in patients aged one year and above and young adults, and for unresectable, recurrent or refractory ALK-positive inflammatory myofibroblastic tumor. Discuss any rarer-indication request with GLT and your treating oncologist together.

How Does the Medicine Act?

Crizotinib inactivates a set of receptor tyrosine kinases — ALK, ROS1, c-Met and RON — by occupying their ATP pockets. In rearrangement-driven cancers these kinases behave like a jammed accelerator; the drug releases it, silencing the PI3K/AKT and MAPK cascades that tumor cells rely on, slowing division and promoting cell death. Response is confined to molecularly positive disease, which is why companion diagnostics gate every start.

Indications Summary

  • ALK-rearranged advanced or metastatic NSCLC
  • ROS1-rearranged advanced NSCLC
  • Reference uses: ALK-positive ALCL (pediatric/young adult) and ALK-positive IMT

Dosage and Administration

Take one 250 mg capsule twice daily, spaced roughly twelve hours, with or without meals. Keep capsules whole; avoid grapefruit juice alongside dosing. When side effects require, oncologists reduce the dose stepwise, and in pronounced renal impairment the schedule may become one capsule per day. The two-capsules-a-day rhythm continues until scans show progression or the body demands a stop.

Side Effects Profile

Typical observations include passing visual glints, queasiness, diarrhea, constipation, leg swelling and tiredness, with liver enzymes trending upward on bloodwork for some patients. The safety warnings that matter most: liver injury, interstitial lung disease or pneumonitis, QT prolongation, bradycardia and serious visual deterioration. Structured monitoring — periodic liver panels, electrolytes and ECGs — plus early dose modification keeps the large majority of patients on therapy.

Storage Guidelines

Store below 30°C in the original packaging, protected from moisture. The bottle format travels safely at ambient temperature; no cold chain applies to this product.

Why Choose the GLT?

Laos has matured into a serious source country for oncology generics, and Pharma 2 Vientiane is one of its anchor factories — but distance and language make verification hard for overseas buyers. GLT bridges that gap as a Hong Kong licensed wholesaler: we confirm stock directly, disclose batch and expiry in writing, and dispatch worldwide with tracking and full export documents. Individual families, treating hospitals and regional distributors all work through the same transparent process.

How to Order PHOCRIZO from GLT

Contact the GLT desk on WhatsApp +86 15234153837 or write to [email protected] with your prescription and molecular test report. We quote the 60-capsule PHOCRIZO 250 pack, share photos of current stock, and arrange insured, trackable shipping to most countries.

FAQ

Q1: What is PHOCRIZO 250?
The crizotinib 250 mg capsule from Pharmaceutical Factory No.2, Vientiane (Pharma 2), packed 60 capsules per bottle — a Lao-made generic of the originator therapy.

Q2: Is PHOCRIZO the same as Xalkori?
Same active molecule and strength; the maker, carton and price differ. Pharmacopoeia-grade crizotinib, sold at Laos economics.

Q3: What does PHOCRIZO cost?
Laotian generics price well below Western brands — ask GLT for the live rate on the 60-capsule pack.

Q4: Where can I buy PHOCRIZO online?
Via GLT: WhatsApp +86 15234153837 or [email protected] — send documents, receive a documented, tracked parcel.

Q5: Does it need refrigeration in transit?
No. Below 30°C, dry, in the original carton — standard courier conditions suffice.

Related Oncology Products

LuciAvat(阿伐曲泊帕)20mg*28片 | 卢修斯制药(老挝)| GLT

LuciAvat——Lucius Pharmaceuticals (Lao) Co., Ltd.(万象)生产的阿伐曲泊帕 20mg(马来酸盐 23.6mg)薄膜衣片。

Barinat(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Natco Pharma Limited | GLT

由 Natco Pharma Limited(印度)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

KeZeRui 科瑞泽(阿伐曲泊帕)20mg*10片 | 四川科伦(中国)| GLT

KeZeRui——四川科伦药业的国采阿伐曲泊帕,中国一体化原料药+片剂制造商。

AVATODX(阿伐曲泊帕)20mg*30片 | 大熊制药(老挝)| GLT

AVATODX——Bigbear Pharmaceutical (Lao) Co., Ltd. 生产的阿伐曲泊帕 20mg,老挝注册号 06L0985/23,30 片瓶装。

Tixepa(替尔泊肽)20mg/2mL 和 30mg/2mL 多剂量注射笔 | Drug International | GLT

Tixepa——Drug International Limited (DIL) 替尔泊肽多剂量注射笔,两种官方规格(Tixepa-5=20mg/2mL,Tixepa-7.5=30mg/2mL)用于 2 型糖尿病和肥胖。

Barinib(巴瑞替尼)2mg | 仿制 JAK1/JAK2 抑制剂 | Drug International Limited | GLT

由 Drug International Limited(孟加拉国)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

SPINRAZA(诺西那生钠)12mg/5mL | 中国购买 | SMA 疗法 | GLT

渤健首创的反义寡核苷酸 SMA 疗法,已获 NMPA 批准并纳入中国国家医保——从 GLT 购买,价格仅为欧美的一小部分。